Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion 1Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion 1

Interventions

Blood Specimen Collection 123Surveys and Questionnaires 82Observation 49Radiotherapy 40Surgical Procedures, Operative 34Drug Therapy 34Biopsy 31Specimen Handling 28Data Collection 27Watchful Waiting 20Interviews as Topic 20Magnetic Resonance Imaging 18Immune Checkpoint Inhibitors 17Liquid Biopsy 16Magnetic Resonance Spectroscopy 15Immunotherapy 15Standard of Care 13pembrolizumab 12Tomography, X-Ray Computed 12Ultrasonography 11trastuzumab deruxtecan 10lenvatinib 10Radiosurgery 10Nivolumab 10Neoadjuvant Therapy 10Carboplatin 10Tissue Banks 9Restraint, Physical 9Radiation 9Endoscopy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Observational × larotrectinib × Clear all
NCT04142437 2026-04-14

ON-TRK

Bayer

Recruiting
150 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

NCT04945330 2026-04-14

NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes

Bayer

Recruiting
100 enrolled
Other solid neoplasm

Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡